Yarbrough Capital, LLC Incyte Corp Transaction History
Yarbrough Capital, LLC
- $2.44 Billion
- Q3 2024
A detailed history of Yarbrough Capital, LLC transactions in Incyte Corp stock. As of the latest transaction made, Yarbrough Capital, LLC holds 4,990 shares of INCY stock, worth $379,888. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,990
Previous 4,990
-0.0%
Holding current value
$379,888
Previous $302,000
8.94%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding INCY
# of Institutions
624Shares Held
198MCall Options Held
766KPut Options Held
476K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.34 Billion24.77% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.63 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.55 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA15.3MShares$1.16 Billion0.58% of portfolio
-
State Street Corp Boston, MA10.9MShares$826 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $16.9B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...